Anonymous
Guest
Anonymous
Guest
This meeting is pointless and a waste of our company's money. We could of handled this via teleconference.
Let me share what's going on with this and other similar meetings:
1) GNE franchises have way too much money to spend and they don't know what to do with it
2) Franchise leaders, all of them (some more than others) "win" their leadership and respect based on how many goodies they throw at all of us.
3) Their leadership is defined by how fabulous they are and how fabulous are the places they go to and take us.
4) GNE is out of touch with the rest of the industry and with real healthcare issues. Patients can't afford our products and we spend very lavishly in all of this. Remember the business we are in
5) We have completely exhausted every subject to talk about and we still have more meetings. We only have one product to sell, very little new data, very high penetration, what's there to strategize and learn?
6) They keep throwing at us more and more useless training and leadership programs. All these consultants hit a goldmine with GNE, we buy everything and we roll out everything.
The gravy train will come to an end and it will hurt!
I was a Roche legacy, came over in the move, and have since moved to another company. You are right about the spending and the "over-meeting". I guess what amazes me most is that outside of Roche legacy brands (the few that are left), the Genentech products have no competitors! That's why they can get away with constantly moving people from one job title to another. You don't need relationships to sell Avastin, or Tarceva, or Activase. Hell, I don't know what the oncology reps do since they can't access most of their customers. Oh, I know what they do...they get ready for the next move and next title. All the while arrogantly walking around like they are the cream of the crop of sales people. As soon as Nutropin started to face competition, they throw in the towel versus trying to battle and discount the product. It seems like a monkey in a suit could be successful selling in oncology or lytics. Although JS may be a monkey in a suit.
Monthly meetings, weekly conference calls, training, special projects, all to justify everyone's existence. Look at all the great Roche reps and managers that were removed from "their" company because they didn't fit in to the Genentech culture of mediocrity.